Laura A Beebe Selected Research

2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- one

5/2005

Does participation in a nurse visitation programme reduce the frequency of adverse perinatal outcomes in first-time mothers?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura A Beebe Research Topics

Disease

6	Tobacco Use Disorder (Nicotine Dependence) 01/2021 - 10/2012
3	Type 2 Diabetes Mellitus (MODY) 03/2023 - 07/2012
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 09/2012 - 03/2010
2	Sudden Infant Death (SID) 12/2015 - 11/2015
2	Heart Diseases (Heart Disease) 12/2015 - 11/2015
1	COVID-19 03/2024
1	Hypertension (High Blood Pressure) 01/2023
1	Neoplasms (Cancer) 01/2020
1	Uterine Cervical Dysplasia 03/2016
1	Overweight 01/2015
1	Weight Gain 01/2015
1	Insulin Resistance 07/2012
1	Birth Weight (Birth Weights) 05/2005

Drug/Important Bio-Agent (IBA)

5	SmokeIBA 03/2023 - 01/2015
4	tyramine-deoxysorbitolIBA 01/2021 - 05/2016
3	CotinineIBA 01/2023 - 10/2012
3	Inosine Triphosphate (ITP)IBA 09/2012 - 03/2010
2	Tobacco Smoke Pollution (Passive Smoking)IBA 12/2015 - 11/2015
1	VaccinesIBA 03/2024
1	CholesterolIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 10/2012
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 07/2012
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 05/2005

Therapy/Procedure

1	Nicotine Replacement Therapy 03/2016